Arrow-right Camera
The Spokesman-Review Newspaper
Spokane, Washington  Est. May 19, 1883

EndNotes

Cancer drug success

In the movie “50/50,” the character played by Joseph Gordon-Levitt undergoes chemotherapy, sees a therapist and ultimately survives. (Associated Press)
In the movie “50/50,” the character played by Joseph Gordon-Levitt undergoes chemotherapy, sees a therapist and ultimately survives. (Associated Press)

The FDA has approved a new class of drugs to fight cancer. The first drug – Keytruda - was approved for patients with advanced melanoma, patients for whom other treatments have failed. Other drugs in trials have been successful against kidney and lung cancers.

The drugs allow one’s own immune system to attack the cancer. As success continues with this new group of drugs, we may see fewer cancer patients prescribed chemotherapy, so toxic and debilitating.   For all cancer patients comes a message of hope.

(S-R archive photo: In the movie “50/50,” the character played by Joseph Gordon-Levitt undergoes chemotherapy, sees a therapist and ultimately survives.)



Spokesman-Review features writer Rebecca Nappi, along with writer Catherine Johnston of Olympia, Wash., discuss here issues facing aging boomers, seniors and those experiencing serious illness, dying, death and other forms of loss.